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Sentinel lymph node biopsy is commonly applied as staging procedure of regional lymph nodes in patients with cutaneous
melanoma. Dynamic lymphoscintigraphy defines the lymphatic pathways from a primary melanoma site and allows to identify the
node receiving lymphatic drainage from the primary tumor, which is the sentinel lymph node. In rare cases, lymphoscintigraphy
shows sites of lymphatic drainage in nonclassical basins never described in the past when lymphatic drainage was considered only
according to the anatomical proximity of the tumor primary site. These peculiar sentinel nodes, so-called “uncommon/interval”
nodes, must be surgically removed because they may contain micrometastatic disease and may be the only site of nodal involve-
ment.
1. Introduction
Sentinel lymph node biopsy (SLNB) is commonly applied
as staging procedure of regional lymph nodes in patients
with cutaneous melanoma. Dynamic lymphoscintigraphy
defines the lymphatic pathways from a primary melanoma
site and allows to identify the node receiving lymphatic
drainage from the primary tumor, which is the sentinel
lymph node [1, 2]. The combinedmodality of the radioactive
colloid, blue dye, and an intraoperative gamma probe allows
the biopsy of the sentinel node (SN), in order to detect
microscopic nodal disease, with accurate selection of patients
for early therapeutic lymphadenectomy or adjuvant therapy.
Although most melanomas drain to the predicted classical
anatomical basins (cervical, axillary, and inguinal nodes),
some patients drain to lymph nodes in unpredicted sites,
so-called interval nodes, aberrant nodes, intercalated, or
unexpected nodes. These “not classical” sentinel nodes are
those lymph nodes lying along the course of a lymphatic
collecting vessel between the primary tumor site and the
draining basin or that lymph nodes located in a nodal
basin outside the anatomical predicted nodal field [3]. These
peculiar sentinel nodes may contain micrometastatic disease
and may be the only site of nodal involvement [4].
2. Sentinel Node Procedure
At the National Cancer Institute of Naples, patients with a
primary tumor thicker than 1mm or at least Clark level
IV-V, ulcerated or with ≥1 mitosis/mm2, without clinical
evidence of nodal metastases, undergo SLNB. Prior to
surgery, we perform clinical evaluation of all patients with
liver ultrasound, chest X-ray, and lactate dehydrogenase to
rule out the presence of distant metastases. Patients who had
received a wide excision of the primary (more than 3 cm) or
had undergone reconstruction with a cutaneous rotation flap
are excluded, because the probable disruption of lymphatic
drainage. Dynamic lymphoscintigraphy is performed 2–4
hours before surgery. A dose of 18MBq 99mTechnetium-
labelled colloidal albumin (nanocoll) colloid is injected
intradermally around the tumor. Dynamic and planar images
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Figure 1: Lymphoscintigram of a patient with a primary melanoma of the forearm, with intense uptake of radioactive colloid in an
epitrochlear node and uptake of the tracer in axillary region.
from different points of view are obtained, and the sentinel
node “hot spot” is marked on the skin.
About 20 minutes before the surgical procedure, 1.0mL
of Patent Blue dye is injected intradermally around the
primary scar. A hand-held gamma probe guides the identi-
fication of sentinel nodes, with correlation of radioactivity in
vivo, ex vivo and in the operative field. Blue lymph nodes
are excised as well any radioactive nodes that exhibit high
level of radioactivity in the operative field. Serial sections
of SN are analyzed by standard stain with hematoxylin
and eosin (H&E) and immunohystochemical (IHC) staining
with S-100 and HMB-45 antibodies. Patients with tumor-
positive SN undergo complete lymph node dissection of the
involved basin. Stage I-II melanoma patients were followed
every three months for the first two years and every six
months thereafter, with clinical evaluation, liver and lymph
nodes ultrasound, serum biochemistry, and chest X-ray every
six months. Computed tomography (CT) and fluorine 18
fluorodeoxyglucose (FDG) positron emission tomography
(PET) and bone scans are performed only in cases of clinical
suspicion of distant extension or recidiva. The follow up for
stage III patients is similar to stage I-II patients, but a total
body CT or FDG PET scan is performed every year [5].
From line 24: The inguinal nodes are considered the
classical nodal basin in the lower extremities, the axillary
nodes are typical basin for the upper extremities. Drainage is
expected to occur to the nearest axillary or inguinal basin in
patients with primary tumor sites in the torso. If a melanoma
is located within 2.5 cm of the midline, the drainage can
occur to either side or both sides and is not considered
discordant. Similarly, for melanomas located within 2.5 cm
of the Sappey line, drainage can occur to the ipsilateral
groin, axilla, or both [6]. For patients with head and
neck primary melanoma all classical five levels in the neck
are considered typical. Parotid, occipital and retroauricolar
nodes are considered as possible standard sites of SN in head
and neck melanomas [7]. All other “non classical” drainage
sites can be classified according to the following terms:
“uncommon” and “interval” sentinel node. An “uncommon”
Table 1
Uncommon SNs Interval SNs
Epitrochlear Chest wall
Popliteal Deep back
Lower neck Flank
Triangular intermuscular space Occipital areas
Internal mammary
Paravertebral
Intraabdominal
(Figure 1) is a sentinel node located in a minor lymphatic
basin along the lymphatic drainage to a major classical
nodal basin. Epitrochlear, popliteal, lower neck, triangular
intermuscular space (TIS), internalmammary, paravertebral,
and intraabdominal (paraaortic and retroperitoneal) may be
considered uncommon sites of sentinel nodes, because these
are anatomically recognized lymphatics areas for which a
described surgical procedure exist. “Interval” (Figure 2) is a
sentinel lymph node lying anywhere along the lymphatics
between the primary tumor site and the nearest lymphatic
basin, like intramuscular or subcutaneous nodes of the chest
wall, deep back, flank, and occipital areas (Table 1). Interval
nodes are not in an anatomical lymphatic basin and may
be identified only by accurate dynamic lymphoscintigraphy.
This classification reflects a different lymphatic pathway and
peculiar surgical and therapeutical options.
3. Clinical Implication and
Surgical Management
The introduction of the sentinel node procedure with
dynamic lymphoscintigraphy opened a new era in the
management of lymph node staging in oncology. Functional
study of the lymphatic pathway has changed the approach
to nodal staging at diagnosis. In the last 15 years the
Sappey’s rules, that governed lymphatic drainage in the last
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Figure 2: Lymphoscintigram of a patient with a primary melanoma in the left flank, demonstrating axillary nodal drainage, and an interval
sentinel node at level of the chest wall.
century, have been changed by dynamic lymphoscintigraphy
to identify the node receiving direct lymphatic drainage from
a primary tumor site. Out of classical lymph node basins,
such as cervical, axillary, and groin, new “nonclassical” node
sites appeared and have been reported widely in literature
with different terms.
The incidence of uncommon/interval sentinel nodes
varies widely in literature from 3.1% to 9.8%. This variability
can be related to the different terms and definitions used to
refer to an uncommon/interval node, to the different tracers
used, and to the different modality of injection of the tracer.
The radiocolloids that best allow the identification of
SNs are those that easily penetrate the lymphatic capillaries
because of the particle sizes of 5–50 nm [1, 8]. McMasters
et al., with 99mTc sulfur colloid radioactive agent, reported
3.1% of interval nodes [4]. Uren et al. reported an incidence
of interval nodes of 7.2% of patients using 99mTc-labelled
antimony trisulfide colloid that is a very small radioactive
particle [3]. Roozendaal et al., like in our institution, used
99mTc-labelled human albumin colloid, with an identifica-
tion rate of interval nodes of 5.8% [9].
High quality lymphoscintigraphy requires specific high-
resolution collimators for optimal gamma-camera imaging,
with the use of detailed imaging protocols, in order to incor-
porate all anatomic areas to exclude uncommon/interval
sentinel nodes sites. The accuracy may reflect a variable iden-
tification rate of unpredicted SNs [4, 10, 11].
Interval nodes were mostly associated with primary
melanomas of the trunk. Uren among 3280 patients with
cutaneous melanoma found 20% unexpected drainage from
primary of the trunk. He described unexpected drainage
from melanomas of the torso to the neck, to the TIS, to
the subcutaneous fat over the costal margin, and also to
the paravertebral, para-aortic, or retroperitoneal areas [12,
13]. The triangular intermuscular space is a well, known
anatomic entity, formed by the teres major inferiorly, the
infraspinatus, teres minor, and subscapularis superiorly, and
the long head of the triceps laterally. Drainage to TIS will
occur in approximately 25% of patients with melanoma
lesions on the trunk [14].
In most cases, drainage from truncal melanomas is
associated to axillary or groin drainage. Recent studies have
suggested that multiple lymphatic drainage in patients with
truncal melanoma, compared with drainage to just one
basin, is independently associated with an increased risk of
lymph node metastases and with a worse prognosis even
when no pathologic lymph node involvement was identified
[15, 16]. This is opposite to McHugh et al., who studied 98
out of 423 (23.2%) patients with primary truncal melanoma
submitted to sentinel biopsy to multiple lymphatic basin
and affirmed that multiple drainage is no an independent
risk factor for nodal metastasis and has not prognostic
significance.Multiple drainagemust be considered only from
a physiological point of view and in these cases, SN biopsy
may be avoided [17].
Uncommon sentinel nodes were frequently identified for
cutaneous melanomas of the extremities. In melanomas of
the upper limb, Uren described drainage in the epitrochlear
region in 20% of patients, in the TIS in 6%, higher than our
series probably due to the different radiotracer used [12]. The
incidence of popliteal SNs was related to the primary sites,
as described by Thompson et al. with a rate of 6.9% [18].
From cutaneous melanoma of the head and neck area, all
nonclassical sentinel nodes were identified as occipital nodes
or postauricolar/mastoid nodes. These sites were considered
uncommon sentinel node, because they are part of the
cervical nodal chain. Lieber et al. did not detect unexpected
nodes in patients with primary head and neck melanomas
submitted to SN biopsy [10]. The sentinel procedure in head
and neck area is often technically more difficult than other
sites, because the closer of the primary tumor, and because
lymph nodes are often small in size [7, 19, 20].
de Wilt et al. demonstrated sentinel nodes in discordant
fields in 31.5% of patients with head and neck melanomas,
4 Radiology Research and Practice
but they considered postauricolar nodes, occipital nodes,
preauricular nodes, cheek nodes, axillary nodes, or sentinel
nodes in the TIS, as unexpected basin demonstrating that
such nodes can easily be overlooked without performing
high, resolution and multiple, view lymphoscintigraphy
[7]. Uren reported 30% of patients with head and neck
melanomas draining in unexpected basin [12].
McMasters et al. in a multicenter study and Tanabe,
found the same frequency of tumor-positive sentinel nodes
in unexpected and classical basin cases [4, 21]. In 11 (85%)
out 13 patients with a positive unexpected sentinel node,
it was the only site of disease. They concluded affirming
that in cases with epitrochlear or popliteal tumor-positive
sentinel node, lymphadenectomy is mandatory. For isolated
interval nodes in other areas, further dissection seems to
be unnecessary, out of evidence of extracapsular nodal
extension.
Sumner III et al. declared that completion lymph node
dissection of both the unexpected site and the regional lymph
node basin upstream from it is always mandatory [22]. It is
our opinion that in the absence of a parallel drainage to a
classical basin revealed at lymphoscintigraphy, in the case of
a positive sentinel node in an unexpected site, the elective
dissection of these basins may be avoided.
4. Conclusions
The introduction of lymphoscintigraphy and sentinel lymph
node biopsy has changed the approach to the staging of
lymph node disease in oncology, permitting to identify
micrometastatic nodal involvement. In rare cases dynamic
lymphoscintigraphy shows sites of lymphatic drainage in
nonclassical basins never described in the past when
lymphatic drainage was considered only according to the
anatomical proximity of the tumor primary site [23, 24].
Despite the different terms used to identify the sentinel node
sites in non classical basins, the distinction between “uncom-
mon” and “interval” sentinel node sites may classify all cases
of nonclassical lymph node drainage with typical lymphatic
pathway and surgical purpose.
For the uncommon sentinel node sites, like popliteal
or epitrochlear, an elective dissection may be adopted, to
avoid a reoperation in case of a positive sentinel node.
Both for uncommon and interval tumor-positive sentinel
node, the extension of surgical dissection to the nearest
classical basin remains controversial but may be avoided
when there is no other parallel basin of drainage identified
at lymphoscintigraphy. This may be true especially for
interval sites that might be considered completely ripped
from the nearest classical basin. For uncommon/interval
intraabdominal or intrathoracic sentinel sites, the biopsy
may be avoided in favor of careful followup with clinical
imaging method.
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